Article on The Task Force for Global Health: “You’ve heard of the CDC, but you probably didn’t know about this under-the-radar nonprofit.” Atlanta Magazine,
“Progress has been made in every area that makes disease elimination and eradication possible — from diagnosis and treatment to mapping and modelling. Now, cross-disease discussions
An article discussing how transmission of disease occurs in only 9 of 36 Ugandan districts since eradication efforts began. Al Jazeera, October 20, 2016.
We are pleased to announce that Dr. Yao Sodahlon, MD, MSc, will become the next Director of the Mectizan Donation Program (MDP), beginning on October 17, 2016. Yao will replace Dr. Adrian Hopkins,
Article about “breaking the life cycle” of onchocerca volvulu, the parasitic worm that causes onchocerciasis, commonly called river blindness. NPR, August 11, 2016.
We are pleased to announce that Dr. Tony Ukety, former Coordinator for the Onchocerciasis Elimination NGDO Group, was selected as the 2016 recipient of
NPR’s Jason Beaubien is interviewed regarding his journey to Ghana, where yearly doses of ivermectin have dramatically reduced the scourge of river blindness, a
An article describing the importance of and complexity in distributing ivermectin annually to people affected by onchocerciasis. NPR, January 14, 2016.
KENILWORTH, N.J.–(BUSINESS WIRE)–Merck (NYSE:MRK), known as MSD outside the United States and Canada, proudly congratulates William C. Campbell (pictured/Reuters/Brian Snyder), a retired scientist from Merck
Please join The Mectizan Donation Program in congratulating the government of Mexico on the elimination of transmission of river blindness. Congratulations also to The
Country efforts supported by a major public-private partnership—including The Carter Center/OEPA, PAHO/WHO, and Merck & Co., Inc.’s Mectizan Donation Program—bring the region closer to achieving
Efforts to Control River Blindness in Africa are a Remarkable Success Story Building Upon the Strength of Diverse and Long Standing Public-Private-Partnerships New World
Scientists from the National Institute of Allergy and Infectious Diseases (NIAID), part of the National Institutes of Health, and the University of California, Berkeley,
